Colorectal cancer is one of the most common malignant tumors, with numerous studies highlighting the role of inflammation in its onset and progression. Cytokines such as IL-6 and TNF-α play a crucial role in sustaining inflammation, contributing to the malignant transformation of cells. The dietary inflammatory index, which reflects the intake of pro-inflammatory nutrients, is associated with an increased risk of developing colorectal cancer. Serum cytokine concentrations may serve as biomarkers for risk assessment, while dietary modifications aimed at reducing inflammation can significantly impact both prevention and therapy. This knowledge opens possibilities for a personalized approach to the treatment and prevention of colorectal cancer.

 

Colorectal Neoplasms, Inflammation, Cytokines, Feeding Behavior

 

1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12–49. doi: 10.3322/caac.21820.
2. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA: Cancer J Clin. 2020; 70(3):145-64. doi: 10.3322/caac.21601.
3. Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ. Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open. 2020; 3(2):e201038. doi: 10.1001/jamanetworkopen.2019.20407.
4. Romano V, Belviso I, Venuta A, Ruocco MR, Masone S, Aliotta F, et al. Influence of tumor microenvironment and fibroblast population plasticity on melanoma growth, therapy resistance, and immunoescape. Int J Mol Sci. 2021;22(10):5283. doi: 10.3390/ijms22105283.
5. Prejac J. Cancer patients during the COVID-19 pandemic. Medicus. 2020; 29(2):249-53. [Article in Croatian].
6. Lin H-Y, Park JY. Epidemiology of cancer. In: Huang J, Huang J, Liu H, editors. Anesthesia for oncological surgery. Cham: Springer International Publishing; 2023. p. 11-6.
7. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA: Cancer J Clin. 2023; 73(3):233-54. doi: 10.3322/caac.21772.
8. Earl V, Beasley D, Ye C, Halpin SN, Gauthreaux N, Escoffery C, et al. Barriers and facilitators to colorectal cancer screening in African-American men. Dig Dis Sci. 2022; 67(2):463–72. doi: 10.1007/s10620-021-06960-0.
9. Zakaria A, Asaduzzaman SAI, Nahar Z, Snigdha HJ, Murshed T, Noor R. A short review of the genes involved in the development and progression of colorectal cancer. Biocell. 2021; 45(3):483-7. doi: 10.32604/biocell.2021.014704
10. Hill M, Morson B, Bussey H. Aetiology of adenoma—carcinoma sequence in large bowel. Lancet. 1978; 1(8058):245-7. doi: 10.1016/s0140-6736(78)90487-7.
11. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009; 9(4):302-12. doi: 10.1038/nrc2627.
12. Shao Y, Yu M, Zhang L, Zhou L, Yan X, Feng B, et al. In-depth analysis of lymph node metastasis-related sialylated protein profiling and their clinical and biological significance in colorectal cancer using mass spectrometry and multi-omics technologies. Sci Rep. 2024; 14(1):28535. doi: 10.1038/s41598-024-79893-z.
13. Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers (Basel). 2024; 16(8):1530. doi: 10.3390/cancers16081530.
14. Klimeck L, Heisser T, Hoffmeister M, Brenner H. Colorectal cancer: A health and economic problem. Best Pract Res Clin Gastroenterol. 2023; 66:101839. doi: 10.1016/j.bpg.2023.101839.
15. Kim HM, Kim TI. Screening and surveillance for hereditary colorectal cancer. Intest Res. 2024;22(2):119–30. doi: 10.5217/ir.2023.00112.
16. Gharib E. Closing editorial: Colorectal cancer—a molecular genetics perspective. Int J Mol Sci. 2024;25(23):12604. doi: 10.3390/ijms252312604.
17. Koya AI, Ibrahim SA. Carcinogenesis. [Updated 2024 Oct 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK604463/
18. Renna ME, Shrout MR, Madison AA, Alfano CM, Povoski SP, Lipari AM, et al. Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation. Psychooncology. 2022; 31(9):1536-44. doi: 10.1002/pon.5986.
19. Keivanlou MH, Amini-Salehi E, Joukar F, Letafatkar N, Habibi A, Norouzi N, et al. Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: A systematic review and meta-analysis. Sci Rep. 2023; 13(1):17457. doi: 10.1038/s41598-023-44487-8.
20. Sheikh-Wu SF, Anglade D, Gattamorta K, Xiao C, Downs CA, editors. Symptom occurrence, frequency, and severity during acute colorectal cancer survivorship. Oncology Nursing Forum; 2022.
21. Yu H, Hemminki K. Genetic epidemiology of colorectal cancer and associated cancers. Mutagenesis. 2020;35(3):207-19. doi: 10.1093/mutage/gez022.
22. Lynch HT, Watson P, Smyrk TC, Lanspa SJ, Boman BM, Boland CR, et al. Colon cancer genetics. Cancer. 1992; 70(5 Suppl):1300-12. doi: 10.1002/1097-0142(19920901)70:3+<1300::aid-cncr2820701517>3.0.co;2-o.
23. Belizon A, Balik E, Horst PK, Kumara HS, Nasar A, Whelan RL. Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma. Dis Colon Rectum. 2009; 52(6):1166-71. doi: 10.1007/DCR.0b013e3181a0b388.
24. Najm A, McInnes IB. IL-23 orchestrating immune cell activation in arthritis. Rheumatology (Oxford). 2021; 60(Suppl 4):iv4–iv15. doi: 10.1093/rheumatology/keab266.
25. Zheng W, Wu J, Peng Y, Sun J, Cheng P, Huang Q. Tumor-associated neutrophils in colorectal cancer development, progression and immunotherapy. Cancers (Basel). 2022; 14(19):4755. doi: 10.3390/cancers14194755.
26. Lopez-Garzon M, Postigo-Martin P, González-Santos Á, Arroyo-Morales M, Achalandabaso-Ochoa A, Férnández-Pérez AM, et al. Colorectal cancer pain upon diagnosis and after treatment: a cross-sectional comparison with healthy matched controls. Supportive Care Cancer. 2022; 30(4):3573-84. doi: 10.1007/s00520-022-06803-2.
27. Li J, Huang L, Zhao H, Yan Y, Lu J. The role of interleukins in colorectal cancer. Int J Biol Sci. 2020; 16(13):2323-39. doi: 10.7150/ijbs.46651.
28. Gocher AM, Workman CJ, Vignali DA. Interferon-γ: teammate or opponent in the tumour microenvironment? Nat Rev Immunol. 2022; 22(3):158-72. doi: 10.1038/s41577-021-00566-3.
29. Braumüller H, Mauerer B, Andris J, Berlin C, Wieder T, Kesselring R. The cytokine network in colorectal cancer: Implications for new treatment strategies. Cells. 2022;12(1):138. doi: 10.3390/cells12010138.
30. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin Gastroenterol Hepatol. 2006; 4(6):754-9. doi: 10.1016/j.cgh.2006.03.028.
31. Ma Y, Zhang Y, Bi Y, He L, Li D, Wang D, et al. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer. Medicine. 2022; 101(37):e30787. doi: 10.1097/MD.0000000000030787.
32. Gulubova M, Chonov D, Aleksandrova E, Ivanova K, Ignatova MM, Vlaykova T. Interleukin-6-positive immune cells as a possible new immunologic marker associated with the colorectal cancer prognosis. Appl Immunohistochem Mol Morphol. 2024;32(5):233-43. doi: 10.1097/PAI.0000000000001198.
33. Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-γ in tumor progression and regression: A review. Biomark Res. 2020; 8:49. doi: 10.1186/s40364-020-00228-x.
34. Kawamura K, Bahar R, Natsume W, Sakiyama S, Tagawa M. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. Cancer Gene Ther. 2002; 9(1):109-15. doi: 10.1038/sj.cgt.7700418.
35. Borowczak J, Szczerbowski K, Maniewski M, Kowalewski A, Janiczek-Polewska M, Szylberg A, et al. The role of inflammatory cytokines in the pathogenesis of colorectal carcinoma—recent findings and review. Biomedicines. 2022;10(7):1670. doi: 10.3390/biomedicines10071670.
36. Damjanov D, Ičin T, Savić Ž, Janjić N, Nikolić S, Bošnjak OL, et al. Visceral fat thickness, serum adiponectin, and metabolic syndrome in patients with colorectal adenomas. J Pers Med. 2024; 14(9):1008. doi: 10.3390/jpm14091008.
37. Barbaresko J, Koch M, Schulze MB, Nöthlings U. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev. 2013; 71(8):511-27. doi: 10.1111/nure.12035.
38. Research WCRFAIfC. Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer. American Institute for Cancer Research Washington, DC; 2011.
39. Azarmanesh D, Bertone-Johnson ER, Pearlman J, Liu Z, Carbone ET. The dietary inflammatory index is inversely associated with depression, which is minimally mediated by C-reactive protein. Nutr Res. 2022;97:11–21. doi: 10.1016/j.nutres.2021.09.002.
40. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014; 17(8):1689-96. doi: 10.1017/S1368980013002115.
41. Mohammadi S, Hosseinikia M, Ghaffarian-Bahraman A, Clark CCT, Davies IG, Yousefi Rad E, et al. Dietary inflammatory index and elevated serum C-reactive protein: A systematic review and meta-analysis. Food Sci Nutr. 2023;11(10):5786–98. doi: 10.1002/fsn3.3553.
42. Hess JM, Stephensen CB, Kratz M, Bolling BW. Exploring the links between diet and inflammation: Dairy foods as case studies. Adv Nutr. 2021;12(Suppl 1):1S–13S. doi: 10.1093/advances/nmab108.
43. Syed Soffian SS, Mohammed Nawi A, Hod R, Ja’afar MH, Isa ZM, Chan HK, et al. Meta-analysis of the association between dietary inflammatory index (DII) and colorectal cancer. Nutrients. 2022;14(8):1555. doi: 10.3390/nu14081555.
44. Hua R, Liang G, Yang F. Meta-analysis of the association between dietary inflammation index and C-reactive protein level. Medicine. 2024;103(19):e38196. doi: 10.1097/MD.0000000000038196.
45. Azarmanesh D, Bertone-Johnson ER, Pearlman J, Liu Z, Carbone ET. The dietary inflammatory index is inversely associated with depression, which is minimally mediated by C-reactive protein. Nutr Res. 2022;97:11-21. doi: 10.1016/j.nutres.2021.09.002.
46. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol. 2011; 106(7):1340-50. doi: 10.1038/ajg.2011.38.
47. Wang S, Wang Y, Hu X, Lu L. Association between dietary inflammation index and asthma-COPD overlap. Sci Rep. 2024;14(1):8077. doi: 10.1038/s41598-024-58813-1.
48. Jia Y, Yan S, Sun M, Yang Y, Wang L, Wu C, et al. Association between dietary inflammatory index and cognitive impairment: A meta-analysis. Front Aging Neurosci. 2023;14:1007629. doi: 10.3389/fnagi.2022.1007629.
49. Jiang C, Yin H, Liu A, Liu Q, Ma H, Geng Q. Dietary inflammatory index and depression risk in patients with chronic diseases and comorbidity. J Affect Disord. 2022;301:307–14. doi: 10.1016/j.jad.2022.01.008.
50. Rafiee P, Shivappa N, Hébert JR, Jaafari Nasab S, Bahrami A, Hekmatdoost A, et al. Dietary inflammatory index and odds of colorectal cancer and colorectal adenomatous polyps in a case-control study from Iran. Nutrients. 2019; 11(6):1213. doi: 10.3390/nu11061213.
51. Abulimiti A, Zhang X, Shivappa N, Hébert JR, Fang Y-J, Huang C-Y, et al. The dietary inflammatory index is positively associated with colorectal cancer risk in a Chinese case-control study. Nutrients. 2020; 12(1):232. doi: 10.3390/nu12010232.
52. Kotemori A, Sawada N, Iwasaki M, Yamaji T, Shivappa N, Hebert JR, et al. Dietary inflammatory index is associated with inflammation in Japanese men. Front Nutr. 2021; 8:604296. doi: 10.3389/fnut.2021.604296.
53. Stephen AM, Cummings JH. Mechanism of action of dietary fibre in the human colon. Nature. 1980; 284(5753):283-4. doi: 10.1038/284283a0.
54. Azarmanesh D, Pearlman J, Carbone ET, DiNatale JC, Bertone-Johnson ER. Construct validation of the dietary inflammatory index (DII) among young college-aged women. Nutrients. 2023;15(21):4553. doi: 10.3390/nu15214553.
55. Shivappa N, Hebert JR, Marcos A, Diaz LE, Gomez S, Nova E, et al. Association between dietary inflammatory index and inflammatory markers in the HELENA study. Mol Nutr Food Res. 2017; 61(6):1600707. doi: 10.1002/mnfr.201600707.
56. Soffian SS, Nawi AM, Hod R, Ja’afar MH, Isa ZM, Chan HK, et al. Meta-analysis of the association between dietary inflammatory index (DII) and colorectal cancer. Nutrients. 2022;14(8):1555. doi: 10.3390/nu14081555.
57. Hébert JR, Shivappa N, Wirth MD, Hussey JR, Hurley TG. Perspective: the Dietary Inflammatory Index (DII)—lessons learned, improvements made, and future directions. Adv Nutr. 2019; 10(2):185-95. doi: 10.1093/advances/nmy071.
58. Papier K, Bradbury KE, Balkwill A, Barnes I, Smith-Byrne K, Gunter MJ, et al. Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK. Nat Commun. 2025;16(1):375. doi: 10.1038/s41467-024-55219-5.
59. Turizo-Smith AD, Córdoba-Hernandez S, Mejía-Guarnizo LV, Monroy-Camacho PS, Rodríguez-García JA. Inflammation and cancer: friend or foe?. Front Pharmacol. 2024;15:1385479. doi: 10.3389/fphar.2024.1385479.
60. Cassotta M, Cianciosi D, De Giuseppe R, Navarro-Hortal MD, Diaz YA, Forbes-Hernández TY, et al. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies. Nutrition 2023;110:111980. doi: 10.1016/j.nut.2023.111980.